Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial von Kordes, Sil, MD, Pollak, Michael N, Prof, Zwinderman, Aeilko H, Prof, Mathôt, Ron A, PhD, Weterman, Mariëtte J, Beeker, Aart, MD, Punt, Cornelis J, Prof, Richel, Dick J, Prof, Wilmink, Johanna W, Dr

Volltext

A phase Ib study of everolimus combined with metformin for patients with advanced cancer von Molenaar, Remco J., van de Venne, Tim, Weterman, Mariëtte J., Mathot, Ron A., Klümpen, Heinz-Josef, Richel, Dick J., Wilmink, Johanna W.

Volltext

A phase I/II, non-randomized, feasibility/safety and efficacy study of the combination of everolimus, cetuximab and capecitabine in patients with advanced pancreatic cancer von Kordes, Sil, Richel, Dick J., Klümpen, Heinz-Josef, Weterman, Mariëtte J., Stevens, Arnoldus J. W. M., Wilmink, Johanna W.

Volltext

Images of God and attitudes towards death in relation to spiritual wellbeing: an exploratory side study of the EORTC QLQ-SWB32 validation study in palliative cancer patients von Kruizinga, Renske, Scherer-Rath, Michael, Schilderman, Johannes B A M, Weterman, Mariëtte, Young, Teresa, van Laarhoven, Hanneke W M

Volltext

Phase I and pharmacokinetic study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced solid malignancies von Deenen, Maarten J., Klümpen, Heinz-Josef, Richel, Dick J., Sparidans, Rolf W., Weterman, Mariette J., Beijnen, Jos H., Schellens, Jan H. M., Wilmink, Johanna W.

Volltext

Survival analysis of a phase IB/II study of everolimus and metformin for patients with advanced cancer von Molenaar, Remco Jurriaan, van de Venne, Tim, Weterman, Mariette, Mathot, Ron, Klumpen, Heinz-Josef, Richel, Dirk, Wilmink, Johanna

Volltext

Phase I study of everolimus combined with metformin for patients with advanced cancer von Molenaar, Remco Jurriaan, van de Venne, Tim, Weterman, Mariette, Klumpen, Heinz-Josef, Mathot, Ron, Richel, Dirk, Wilmink, Johanna

Volltext